EDITORIAL
Copyright ©2011 Baishideng Publishing Group Co.
World J Cardiol. Feb 26, 2011; 3(2): 43-47
Published online Feb 26, 2011. doi: 10.4330/wjc.v3.i2.43
Table 1 One-year clinical outcomes in selected randomized ST segment myocardial infarction trials from 2000 to 2010
StudyYrInterventionControlnAll-cause death (%)Cardiac mortality (%)MI (%)
CSCSCS
NORDISTEMI[16]2010All PCISelective2763.02.2NANA9.03.0
HORIZONS AMI[17]2009BivalurudinHep/Gp36024.83.53.82.1NANA
TAPAS[5]2008TA + PCIPCI/no TA10717.64.76.73.64.32.2
DANAMI-2[18]2008PCILytic14241.31.4NANA0.91.3
Transfer with Tirofiban for PCI2007Transfer/PCILytic401NANA12.57.07.53.5
Thrombolysis with STEMI[19]
SESAMI[20]2007DESBMS3204.31.8NANA1.81.8
TYPHOON[21]2006DESBMS7122.22.31.42.01.41.1
PASSION[22]2006DESBMS619NANA6.54.51.91.6
ADMIRAL[23]2004Abciximab + PCIPCI40012.56.010.55.06.01.0
STENTIM-2[24]2000BMSBA2111.93.0NANA5.54.0
Table 2 Randomized studies utilizing manual aspiration devices in ST segment myocardial infarction and primary percutaneous coronary intervention1
StudyYrnDevicePrimary endpoint(s)Outcomes1
EXPIRA[14]2009175Export (Medtronic, Minneapolis, MN, USA)MBG > 2, STRImprovement
VAMPIRE[11]2008355TVAC (Nipro, Osaka, JP)SR or NRTrend to improvement
TAPAS[5]20081071Export (Medtronic, Minneapolis, MN, USA)MBGImprovement
De Luca et al[8]200676Diver CE (Invatec, Brescia, IT)MBG > 2, STRImprovement
Kaltoft et al[9]2006215Rescue (BSC, Maple Grove, MN, USA)Myocardial salvageNo improvement
DEAR-MI[10]2006148Pronto (Vascular Solutions, Minneapolis, MN, USA)STR, MBG 3Improvement
REMEDIA[6]200599Diver CE (Invatec, Brescia, IT)MBG > 2, STRImprovement